Mechanism of action
EVENITY inhibits the action of sclerostin, a regulatory factor in bone metabolism.
General use cases
- Osteoporosis, Postmenopausal
- osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
